Warning! High revision rates with Smith & Nephew Journey BCS knees

Smith & Nephew warns on first-gen Journey BCS knee revision rate (MassDevice)

Smith & Nephew (NYSE:SNN) recently released an urgent field safety notice warning of issues with components in the first generation of its Journey BCS knee system that can lead to a higher rate of revisions than expected.
The notice, originally sent in June, warned that post-market surveillance data showed that patients implanted with the first gen Journey BCS knee “may have a higher risk of requiring a revision earlier than they or their surgeon had expected,” though it said that the reason for the revisi...


Your friends are reading OrthoStreams daily - Are you ?

 

Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.

Just $1/day.